Application of arsenic as a cancer and heart disease prevention agent
OwnerGary Kayajanianinventor
Life of this patent
Estimating the term…
Abstract
Modest levels of arsenicals in drinking water (roughly 25-<75 μg/L or ppb) are associated with significant reductions of specified and/or total cancers in men and women and of heart disease in men.
Claims20
A method for reducing total cancer morbidity and mortality in women by adjusting the arsenic level in drinking water to 25-<75 μg/L.
A method for reducing cancer mortality in men by adjusting the arsenic level in drinking water to 42-60 μg/L.
A method for reducing heart disease mortality in men by adjusting the arsenic level in drinking water to 25-<75 μg/L.
A method for not increasing total cancer morbidity and mortality in humans by maintaining the arsenic level in drinking water between 25-<75 μg/L even though such maintenance would violate the newly enacted 10 g upper bound EPA standard.
A method for not increasing heart disease mortality in men by maintaining the arsenic level in drinking water between 25-<75 μg/L even though such maintenance would violate the newly enacted 10 μg/L upper bound EPA standard.
Dependencies are inferred from the claim text.